FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Abbott (NYSE:ABT) today announced a significant milestone abroad with the opening of a new manufacturing facility in Ireland.

Abbott's Freestyle Libre 2 and 3 are the first CGMs to receive FDA clearance for use during imaging tests like X-rays, CT ...

A major development towards the goal of patient and provider choice, the cloud-to-cloud integration will provide an automatic ...

Abbott's FreeStyle Libre Report: The Power of Positive Motivation for Type 2 Diabetes Management explores the experiences of Canadians with type 2 diabetes and the factors influencing their care.

Abbott's FreeStyle Libre 2 and 3 continuous glucose monitors no longer need to be removed for imaging tests. CGM readings during an MRI may be affected for up to an hour after the procedure. While ...

Great Britain's Duncan Scott claimed victory in the men's 200m freestyle on the third and final day of the short course World Cup event in Shanghai. The 27-year-old put in a strong showing in the ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

The device is similar to Abbott’s FreeStyle Libre, which people with diabetes have been using for years to track their glucose levels. Each disc remains on the arm for 14 days before it must be ...